10.87
+0.044(+0.41%)
Currency In USD
Address
Bellevue Centre
West Vancouver, BC V7T 2X1
Canada
Phone
604 921 1810
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
March 14, 2012
| Name | Title | Pay | Year Born |
| Dr. William V. Williams FCPA, M.D. | Chief Executive Officer, President & Director | 734,419 | 1955 |
| Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 241,138 | 1946 |
| Dr. Miguel A. Lopez-Lago Ph.D. | Chief Scientific Officer | 357,745 | 1970 |
| Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | Chief Financial Officer & Corporate Secretary | 443,000 | 1973 |
| Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 540,329 | 1962 |
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
